Last reviewed · How we verify

NCT05710172

Evaluation of Auditory Mirror-therapy for Tinnitus

Active, enrolled NA Last updated 15 May 2025
What this trial tests

NA trial testing Auditory Mirror Therapy in Tinnitus in 50 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
4 October 2022
Primary endpoint
20 November 2023
30 November 2025

Quick facts

Lead sponsorSpaulding Rehabilitation Hospital
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment50
Start date4 October 2022
Primary completion20 November 2023
Estimated completion30 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Spaulding Rehabilitation Hospital

Who can join

Adults 18 to 80, any sex, with Tinnitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will evaluate the effects of wearing auditory mirror earmuffs on tinnitus and on audiometry.The auditory mirror earmuffs is a device that re-routes auditory input from the left side of the head to the right ear, and vice verse, thereby flipping the auditory input. This procedure is called Auditory Mirror Therapy (AMT).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tinnitus

Currently open trials in the same condition.

Other Spaulding Rehabilitation Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05710172.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing